论文部分内容阅读
目的:探讨新生儿肺炎应用沐舒坦雾化吸入联合静脉注射治疗的临床疗效。方法:将92例新生儿肺炎患儿按照随机数字表法均分为两组:治疗组46例给予沐舒坦雾化吸入联合静脉注射治疗,对照组46例给予沐舒坦静脉注射治疗,对比两组疗效和临床症状消失时间。结果:治疗组肺啰音、气喘、咳嗽消失时间均较对照组显著缩短(P<0.05);治疗组治疗总有效率为97.83%,较对照组的86.96%显著提高(P<0.05)。结论:对于新生儿肺炎患儿,给予沐舒坦雾化吸入联合静脉注射治疗较单独静脉注射而言,可显著提高治疗效果,加快患儿康复,值得推广。
Objective: To investigate the clinical efficacy of mucosolvan inhalation combined with intravenous injection in the treatment of neonatal pneumonia. Methods: 92 children with neonatal pneumonia were randomly divided into two groups according to the random number table: 46 patients in the treatment group were given mucosolvan inhalation combined with intravenous injection, 46 patients in the control group were treated with mucosolvan intravenously, compared with two groups Efficacy and clinical symptoms disappear time. Results: The pulmonary rales, asthma and cough disappeared in the treatment group were significantly shorter than those in the control group (P <0.05). The total effective rate of the treatment group was 97.83%, which was significantly higher than that of the control group (86.96%, P <0.05). Conclusion: For children with neonatal pneumonia, the combination of mucosolvan inhalation and intravenous injection can significantly improve the therapeutic effect and accelerate the recovery of children, which is worthy of promotion.